Intellia Therapeutics (NTLA) Tax Rate (2015)

Intellia Therapeutics' (NTLA) quarterly Tax Rate came in at 4.48% in Q4 2015, down 47.56% on a QoQ basis from 8.54% in Q3 2015.

Intellia Therapeutics (NTLA) Tax Rate (2015) Analysis & Trends

Intellia Therapeutics (NTLA) has 1 years of Tax Rate data on file, last reported at 4.48% in Q4 2015.

On a quarterly basis, Tax Rate changed N/A year-over-year to 4.48% in Q4 2015; TTM through Sep 2016 was 0.93%, a N/A change from a year earlier, with the FY2015 full-year figure at 7.55%, changed N/A from the prior year.
Tax Rate for Q4 2015 stood at 4.48%, down from 8.54% in the prior quarter.
Over the last five years, Tax Rate for NTLA reached as high as 11.16% in Q2 2015 and fell as low as 4.48% in Q4 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-0.34
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	5.61
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	12.29
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	17.68
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	12.51
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-13.70
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Intellia Therapeutics	1.27 Bn	1.27 Bn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2015	4.48
Dec 31, 2015	4.48
Dec 31, 2015	4.48
Sep 30, 2015	8.54
Sep 30, 2015	8.54
Sep 30, 2015	8.54
Jun 30, 2015	11.16
Jun 30, 2015	11.16
Jun 30, 2015	11.16
Mar 31, 2015	8.54
Mar 31, 2015	8.54
Mar 31, 2015	8.54